• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙化性主动脉瓣狭窄——疾病获得性机制及治疗综述

Calcific Aortic Stenosis-A Review on Acquired Mechanisms of the Disease and Treatments.

作者信息

Zebhi Banafsheh, Lazkani Mohamad, Bark David

机构信息

Department of Mechanical Engineering, Colorado State University, Fort Collins, CO, United States.

Medical Center of the Rockies, University of Colorado Health, Loveland, CO, United States.

出版信息

Front Cardiovasc Med. 2021 Sep 17;8:734175. doi: 10.3389/fcvm.2021.734175. eCollection 2021.

DOI:10.3389/fcvm.2021.734175
PMID:34604358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8486019/
Abstract

Calcific aortic stenosis is a progressive disease that has become more prevalent in recent decades. Despite advances in research to uncover underlying biomechanisms, and development of new generations of prosthetic valves and replacement techniques, management of calcific aortic stenosis still comes with unresolved complications. In this review, we highlight underlying molecular mechanisms of acquired aortic stenosis calcification in relation to hemodynamics, complications related to the disease, diagnostic methods, and evolving treatment practices for calcific aortic stenosis.

摘要

钙化性主动脉瓣狭窄是一种进行性疾病,在近几十年来变得更加普遍。尽管在揭示潜在生物力学机制的研究以及新一代人工瓣膜和置换技术的开发方面取得了进展,但钙化性主动脉瓣狭窄的管理仍存在未解决的并发症。在本综述中,我们重点介绍了获得性主动脉瓣狭窄钙化与血流动力学相关的潜在分子机制、与该疾病相关的并发症、诊断方法以及钙化性主动脉瓣狭窄不断发展的治疗实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/27424368385c/fcvm-08-734175-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/6ebdce9a9523/fcvm-08-734175-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/4fff72910859/fcvm-08-734175-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/1a5b395ec0cb/fcvm-08-734175-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/27424368385c/fcvm-08-734175-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/6ebdce9a9523/fcvm-08-734175-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/4fff72910859/fcvm-08-734175-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/1a5b395ec0cb/fcvm-08-734175-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/163a/8486019/27424368385c/fcvm-08-734175-g0004.jpg

相似文献

1
Calcific Aortic Stenosis-A Review on Acquired Mechanisms of the Disease and Treatments.钙化性主动脉瓣狭窄——疾病获得性机制及治疗综述
Front Cardiovasc Med. 2021 Sep 17;8:734175. doi: 10.3389/fcvm.2021.734175. eCollection 2021.
2
Osseous and chondromatous metaplasia in calcific aortic valve stenosis.钙化性主动脉瓣狭窄中的骨化生和软骨化生
Cardiovasc Pathol. 2016 Jan-Feb;25(1):18-24. doi: 10.1016/j.carpath.2015.08.008. Epub 2015 Aug 29.
3
Transcatheter aortic valve replacement in patients with non-calcific aortic stenosis.经导管主动脉瓣置换术治疗非钙化性主动脉瓣狭窄患者。
EuroIntervention. 2018 Feb 2;13(15):e1756-e1763. doi: 10.4244/EIJ-D-17-00584.
4
Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.经导管主动脉瓣叶撕裂术预防经导管主动脉瓣置换术中冠状动脉阻塞:概念到首例人体。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):677-689. doi: 10.1016/j.jcin.2018.01.247.
5
Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology.因狭窄接受主动脉瓣置换术患者的人口统计学特征:与瓣膜形态的关系。
Heart. 1996 Feb;75(2):174-8. doi: 10.1136/hrt.75.2.174.
6
Ex vivo assessment of valve thickness/calcification of patients with calcific aortic stenosis in relation to in vivo clinical outcomes.钙化性主动脉瓣狭窄患者瓣膜厚度/钙化的体外评估与体内临床结局的关系。
J Mech Behav Biomed Mater. 2017 Oct;74:324-332. doi: 10.1016/j.jmbbm.2017.06.020. Epub 2017 Jun 22.
7
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: From Computed Tomography to BASILICA.经导管主动脉瓣置换术中预防冠状动脉阻塞:从计算机断层扫描到 BASILICA。
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1197-1216. doi: 10.1016/j.jcin.2019.04.052.
8
Coronary ostial eccentricity in severe aortic stenosis: Guidance for BASILICA transcatheter leaflet laceration.严重主动脉瓣狭窄的冠状动脉开口偏心:BASILICA 经导管瓣叶撕裂的指导。
J Cardiovasc Comput Tomogr. 2020 Nov-Dec;14(6):516-519. doi: 10.1016/j.jcct.2020.02.006. Epub 2020 Mar 19.
9
Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.脂蛋白(a)与钙化性主动脉瓣狭窄:系统综述。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):496-502. doi: 10.1016/j.pcad.2020.06.002. Epub 2020 Jun 8.
10
Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation.老年患者钙化性主动脉瓣狭窄的尸检及术中球囊瓣膜成形术:成功扩张的机制
J Am Coll Cardiol. 1987 Mar;9(3):655-60. doi: 10.1016/s0735-1097(87)80061-x.

引用本文的文献

1
Aortic Stenosis: Diagnosis, Molecular Mechanisms and Therapeutic Strategies-A Comprehensive Review.主动脉瓣狭窄:诊断、分子机制及治疗策略——全面综述
J Clin Med. 2025 Jul 12;14(14):4949. doi: 10.3390/jcm14144949.
2
Sodium-Glucose Cotransporter 2 Inhibitors in Aortic Stenosis: Toward a Comprehensive Cardiometabolic Approach.钠-葡萄糖协同转运蛋白2抑制剂在主动脉瓣狭窄中的应用:迈向全面的心脏代谢治疗方法
Int J Mol Sci. 2025 May 8;26(10):4494. doi: 10.3390/ijms26104494.
3
Paeonol from attenuates calcification of aortic valvular interstitial cell by inhibiting activation of redox-sensitive NFκB/AKT/ERK1/2 pathway.

本文引用的文献

1
Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease.种族和民族在冠心病、血管疾病、结构性心脏病和先天性心脏病方面的差异。
Catheter Cardiovasc Interv. 2021 Aug 1;98(2):277-294. doi: 10.1002/ccd.29745. Epub 2021 May 19.
2
Impact of BASILICA on the thrombogenicity potential of valve-in-valve implantations.BASILICA 对经导管主动脉瓣置换术中血栓形成潜力的影响。
J Biomech. 2021 Mar 30;118:110309. doi: 10.1016/j.jbiomech.2021.110309. Epub 2021 Feb 8.
3
Sex and Race Differences in the Pathophysiology, Diagnosis, Treatment, and Outcomes of Valvular Heart Diseases.
丹皮酚通过抑制氧化还原敏感的NFκB/AKT/ERK1/2信号通路激活减轻主动脉瓣间质细胞钙化。
Food Sci Biotechnol. 2025 Feb 20;34(10):2269-2279. doi: 10.1007/s10068-025-01838-7. eCollection 2025 Jun.
4
Bibliometric analysis of treatment modalities in calcific aortic valve stenosis.钙化性主动脉瓣狭窄治疗方式的文献计量分析
Front Pharmacol. 2025 Mar 13;16:1431311. doi: 10.3389/fphar.2025.1431311. eCollection 2025.
5
Communication between endothelial cells and osteoblasts in regulation of bone homeostasis: Notch players.内皮细胞与成骨细胞在骨稳态调节中的通讯:Notch信号相关因子
Stem Cell Res Ther. 2025 Feb 7;16(1):56. doi: 10.1186/s13287-025-04176-x.
6
Association between triglyceride-glucose-body mass index and risk of aortic stenosis progression in patients with non-severe aortic stenosis: a retrospective cohort study.甘油三酯-血糖-体重指数与非重度主动脉瓣狭窄患者主动脉瓣狭窄进展风险的关联:一项回顾性队列研究
Cardiovasc Diabetol. 2025 Jan 29;24(1):46. doi: 10.1186/s12933-025-02579-x.
7
Exposure and outcomes of aortic valve change in patients initiating dialysis.开始透析的患者主动脉瓣改变的暴露情况及结局
Clin Exp Nephrol. 2025 Jan;29(1):91-98. doi: 10.1007/s10157-024-02548-w. Epub 2024 Aug 22.
8
Does Atrial Fibrillation at Diagnosis Change Prognosis in Patients with Aortic Stenosis?诊断时的心房颤动会改变主动脉瓣狭窄患者的预后吗?
J Clin Med. 2024 Jul 4;13(13):3917. doi: 10.3390/jcm13133917.
9
Effectiveness of Gabapentin as a Benzodiazepine-Sparing Agent in Alcohol Withdrawal Syndrome.加巴喷丁作为苯二氮䓬类药物戒断综合征辅助治疗药物的疗效。
Medicina (Kaunas). 2024 Jun 19;60(6):1004. doi: 10.3390/medicina60061004.
10
Osteopontin stabilization and collagen containment slows amorphous calcium phosphate transformation during human aortic valve leaflet calcification.骨桥蛋白稳定和胶原限制可减缓人主动脉瓣叶钙化过程中无定形磷酸钙的转化。
Sci Rep. 2024 May 28;14(1):12222. doi: 10.1038/s41598-024-62962-8.
性与种族差异对瓣膜性心脏病的病理生理学、诊断、治疗和结局的影响。
Can J Cardiol. 2021 Jul;37(7):980-991. doi: 10.1016/j.cjca.2021.02.003. Epub 2021 Feb 11.
4
Genome-Wide Association Study Highlights as a Novel Locus for Lipoprotein(a) Levels-Brief Report.全基因组关联研究强调 是脂蛋白(a)水平的新位点-简要报告。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):458-464. doi: 10.1161/ATVBAHA.120.314965. Epub 2020 Oct 29.
5
Sex-Specific Features of Calcific Aortic Valve Disease.主动脉瓣钙化性疾病的性别特征。
Int J Mol Sci. 2020 Aug 6;21(16):5620. doi: 10.3390/ijms21165620.
6
Age, Sex, and Valve Phenotype Differences in Fibro-Calcific Remodeling of Calcified Aortic Valve.年龄、性别与钙化性主动脉瓣纤维-钙化重塑中瓣膜表型的差异。
J Am Heart Assoc. 2020 May 18;9(10):e015610. doi: 10.1161/JAHA.119.015610. Epub 2020 May 8.
7
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.经导管主动脉瓣置换术与外科主动脉瓣置换术在低危患者中的超声心动图结果:PARTNER 3 试验。
Circulation. 2020 May 12;141(19):1527-1537. doi: 10.1161/CIRCULATIONAHA.119.044574. Epub 2020 Apr 10.
8
Innate and adaptive immunity in cardiovascular calcification.先天性和适应性免疫在心血管钙化中的作用。
Atherosclerosis. 2020 Aug;306:59-67. doi: 10.1016/j.atherosclerosis.2020.02.016. Epub 2020 Feb 28.
9
Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trials.低风险患者的经导管主动脉瓣置换术:PARTNER 3和Evolut低风险试验综述
Cardiovasc Diagn Ther. 2020 Feb;10(1):59-71. doi: 10.21037/cdt.2019.09.12.
10
Timing of Intervention in Aortic Stenosis.主动脉瓣狭窄的干预时机。
N Engl J Med. 2020 Jan 9;382(2):191-193. doi: 10.1056/NEJMe1914382. Epub 2019 Nov 16.